Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v6-EN
Language English English
Date Updated 2020-08-18 2020-08-18
Drug Identification Number 02339358 02339358
Brand name PLASMA-LYTE A INJECTION PLASMA-LYTE A INJECTION
Common or Proper name PLASMA-LYTE A (An Electrolyte Solution) Injection PLASMA-LYTE A (An Electrolyte Solution) Injection
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients SODIUM CHLORIDE SODIUM ACETATE SODIUM GLUCONATE POTASSIUM CHLORIDE MAGNESIUM CHLORIDE SODIUM CHLORIDE SODIUM ACETATE SODIUM GLUCONATE POTASSIUM CHLORIDE MAGNESIUM CHLORIDE
Strength(s) 526MG 368MG 502MG 37MG 30MG 526MG 368MG 502MG 37MG 30MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 1000mL 12EA/CA (JB2544) 1000mL 12EA/CA (JB2544)
ATC code B05BB B05BB
ATC description I.V. SOLUTIONS I.V. SOLUTIONS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2020-08-17 2020-08-17
Actual start date 2020-08-17 2020-08-17
Estimated end date 2020-08-31 2020-08-31
Actual end date 2020-08-17 2020-08-17
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Duplicate Entry. Pease refer to the actual entry of Report ID 122375 for the drug shortage info. Duplicate Entry. Pease refer to the actual entry of Report ID 122375 for the drug shortage info.
Health Canada comments